Overview

Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy

Status:
Unknown status
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
Examine the efficacy of brinzolamide for the treatment of central serous chorioretinopathy
Phase:
Phase 2
Details
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Treatments:
Brinzolamide